e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnostic features of tuberculosis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome
Y. W. Huang, H. C. Tsai, C. M. Chen, Y. Y. Yu, G. H. Shen, W. T. Yang (Changhua, Taichung, Taiwan)
Source:
Annual Congress 2013 –Diagnostic features of tuberculosis I
Session:
Diagnostic features of tuberculosis I
Session type:
Thematic Poster Session
Number:
2785
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. W. Huang, H. C. Tsai, C. M. Chen, Y. Y. Yu, G. H. Shen, W. T. Yang (Changhua, Taichung, Taiwan). Evaluate the potential of IP-10 as biomarker for the MDR-TB treatment outcome. Eur Respir J 2013; 42: Suppl. 57, 2785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
An mRNA based IP-10 release assay for LTBI combining RT-qPCR and dried blood spots
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Significance of interferon gamma-inducible chemokines in pleural effusions
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of
mycobacterium tuberculosis
infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
LATE-BREAKING ABSTRACT: The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept